protein misfolding

New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases
Endpoints
Tue, 02/8/22 - 10:10 am
Congruence Therapeutics
funding
OrbiMed
Vertex Pharmaceuticals
protein misfolding
cystic fibrosis